Related Experiment Videos
Summary
One percent lignocaine, administered intravenously at 1 mg/kg over 90 seconds, offers a viable alternative treatment for common and classic migraine headaches. This method provides a safe and effective option for migraine management.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a common neurological disorder with significant impact.
- Existing treatments for migraine have limitations and side effects.
Purpose of the Study:
- To evaluate the efficacy of intravenous lignocaine as a treatment for classic and common migraine.
Main Methods:
- Intravenous lignocaine administration at a dose not exceeding 1 mg/kg over 90 seconds.
- Study population included patients with classic and common migraine.
Main Results:
- One percent lignocaine administered intravenously proved to be an effective treatment option.
- The dosage and administration method were well-tolerated.
Conclusions:
- Intravenous lignocaine is a promising alternative therapy for managing classic and common migraines.
- Further research may explore long-term efficacy and optimal dosing.